Plain-English explainers, clinician-reviewed protocol guides, and glossary entries that translate the science behind the storefront.
Enclomiphene is a SERM that raises endogenous testosterone without the HPG axis suppression of conventional TRT. Here is when it makes sense as an alternative, who responds, and where it falls short.
Testosterone replacement therapy comes in injectable, oral, and transdermal forms. Each has distinct pharmacokinetics, dosing flexibility, and side effect profiles. Here is the clinician-reviewed comparison.
Rapamycin is the most-discussed off-label longevity intervention of the past decade. Here is what the published research actually shows, what remains unanswered, and what an honest clinician will tell you about the dosing landscape.
Sermorelin, ipamorelin, CJC-1295, and tesamorelin are growth hormone releasing peptides marketed for body composition and recovery. Here is what they actually do, what is FDA-approved, and what is off-label.
BPC-157 is one of the most-discussed peptides in the wellness space, with claims ranging from tendon healing to gut repair. Here is an honest review of what is published, what is preclinical, and what is unproven.
Low-dose daily tadalafil is FDA-approved for ED and BPH, and is the only PDE5 inhibitor with an approved daily dosing schedule. Here is when daily dosing makes sense, when it does not, and what to expect.
Tadalafil and sildenafil are the two most prescribed PDE5 inhibitors for erectile dysfunction. They share a mechanism but differ meaningfully in onset, duration, food sensitivity, and dosing flexibility. Here is the clinician-reviewed comparison.
Topical and oral hair loss treatments are not interchangeable. They reach different concentrations at the follicle, carry different side effect profiles, and suit different patients. Here is the clinician-reviewed comparison.
Finasteride is the most studied oral medication for male pattern hair loss. Here is how the molecule works, what the long-term clinical data shows, and what realistic expectations look like — including the side effects that get the most attention online.
GLP-1 medications are titrated slowly for a reason. Here is the pharmacological rationale, the standard escalation schedules for semaglutide and tirzepatide, and what to expect at each step.
Enclomiphene stimulates endogenous testosterone production while preserving fertility—an off-label alternative to exogenous TRT for select men.
Injectable, oral, and transdermal testosterone replacement differ in bioavailability, monitoring needs, and peak-trough variability. Here's what the evidence shows.
GLP-1 receptor agonists like semaglutide and tirzepatide can cause nausea, constipation, and other GI side effects. Here's how to manage them.
Compounded semaglutide and tirzepatide differ from branded GLP-1s in regulation, sourcing, and FDA status. Here's what patients need to know.
